BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 12, 2024
Home
»
Authors
» Karl Thiel
Karl Thiel
Articles
ARTICLES
The Best and Worst of Biotech in 2008
Jan. 5, 2009
By
Karl Thiel
No Comments
New Washington Alignments Bring Period of Uncertainty
Dec. 1, 2008
By
Karl Thiel
No Comments
How Biotech Can Make Even Cash Look Bad
Nov. 3, 2008
By
Karl Thiel
No Comments
Has the Economic Mess Diluted Biotech's Hand?
Sep. 29, 2008
By
Karl Thiel
No Comments
Good News from Capital Markets: Some VCs Taking a Long View
Sep. 2, 2008
By
Karl Thiel
No Comments
Are Biotechs Build to Prosper or Are They Built to be Sold?
Aug. 4, 2008
By
Karl Thiel
No Comments
Two-Year DTC Ad Moratorium Weakens Patient Education Role
June 30, 2008
By
Karl Thiel
No Comments
Election 2008: Say Hail to the Chief of Scientific Illiteracy
June 2, 2008
By
Karl Thiel
No Comments
Japan Pharmas' Love for U.S. Biotechs Just Heating Up
April 28, 2008
By
Karl Thiel
No Comments
The FDA is Treading Water Until a True Leader Arrives
March 31, 2008
By
Karl Thiel
No Comments
View All Articles by Karl Thiel
